The impact of six-week dihydrogen-pyrroloquinoline quinone supplementation on mitochondrial biomarkers, brain metabolism, and cognition in elderly individuals with mild cognitive impairment: a randomized controlled trial-Reference-Cited by-同舟云学术

The impact of six-week dihydrogen-pyrroloquinoline quinone supplementation on mitochondrial biomarkers, brain metabolism, and cognition in elderly individuals with mild cognitive impairment: a randomized controlled trial

Published:2024-08 Issue:8 Volume:28 Page:100287
ISSN:1279-7707
Container-title:The Journal of nutrition, health and aging
language:en
Short-container-title:The Journal of nutrition, health and aging

Author:

Baltic Sonja,Nedeljkovic David,Todorovic Nikola,Ranisavljev Marijana,Korovljev Darinka,Cvejic Jelena^ORCID,Ostojic Jelena^ORCID,LeBaron Tyler W.,Timmcke Judi,Stajer Valdemar,Ostojic Sergej M.^ORCID

Funder

Provincial Secretariat for Higher Education and Scientific Research, Autonomous Province of Vojvodina

Autonomous Province of Vojvodina Provincial Secretariat for Higher Education and Scientific Research Activities

Publisher

Elsevier BV

Reference35 articles.

1. Mild cognitive impairment: clinical characterization and outcome;Petersen;Arch Neurol.,1999

2. Estimating the prevalence of dementia and mild cognitive impairment in the US: the 2016 health and retirement study harmonized cognitive assessment protocol project;Manly;JAMA Neurol.,2022

3. Quality of life and disease burden in patients with MCI and dementia: epidemiology/prevalence, incidence, and outcomes of MCI and dementia;Moon;Alzheimers Dementia.,2020

4. Over-the-counter supplement interventions to prevent cognitive decline, mild cognitive impairment, and clinical Alzheimer-type dementia: a systematic review;Butler;Ann Intern Med.,2018

5. Dietary pattern, food, and nutritional supplement effects on cognitive outcomes in mild cognitive impairment: a systematic review of previous reviews;Andrews;Nutr Rev.,2023